[1]郑德璇,段华*,汪沙,等.局部粘着斑激酶和钙粘素E在子宫腺肌病子宫内膜中的表达与意义[J].中国计划生育和妇产科,2018,(2):27-31.
 ZHENG De-xuan,DUAN Hua*,WANG Sha,et al.Expression of FAK and E-cadherin in the endometrium of patients with adenomyosis[J].Chinese Journal of Family Planning & Gynecotokology,2018,(2):27-31.
点击复制

局部粘着斑激酶和钙粘素E在子宫腺肌病子宫内膜中的表达与意义
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2018年2期
页码:
27-31
栏目:
论著与临床
出版日期:
2018-02-25

文章信息/Info

Title:
Expression of FAK and E-cadherin in the endometrium of patients with adenomyosis
作者:
郑德璇段华*汪沙徐倩董千靖
首都医科大学附属北京妇产医院妇科微创中心
Author(s):
ZHENG De-xuan DUAN Hua* WANG Sha XU Qian DONG Qian-jing
Gynecology Minimally Invasive Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100006, P.R.China
关键词:
子宫腺肌病子宫内膜FAKE-cadherin
Keywords:
endometrium FAK E-cadherin adenomyosis
分类号:
R 737.33
摘要:
目的探讨局部粘着斑激酶(focal adhesion kinase, FAK)和钙粘素E(E-cadherin)在子宫腺肌病(adenomyosis,ADS)患者子宫内膜组织中的表达、意义及相关性。方法选择2015~2016年首都医科大学附属北京妇产医院收治的24例ADS患者为ADS组,23例无子宫内膜病变的患者为对照组,获取子宫内膜组织标本。采用免疫组化染色方法检测两组子宫内膜组织中FAK和E-cadherin的表达情况。结果FAK在ADS组表达 (10660±0259)高于对照组(8357±0
Abstract:
ObjectiveTo estimate the expression of focal adhesion kinase (FAK) and E-cadherin in the endometrium of adenomyosis(ADS) and non-adenomyosis specimens. MethodsThe endometrium specimens from patients undergoing hysteroscopy for confirmed adenomyosis(n=24:

参考文献/References:

[1]LILI L N, MATYUNINA L V, WALKER L D, et al. Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis [J]. Journal of Ovarian Research, 2013, 6(1): 49. [2]COX B D, NATARAJAN M, STETTNER M R, et al. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation [J]. Journal of Cellular Biochemistry, 2006, 99(1): 35-52. [3]GOI G M, EPIFANO C, BOSKOVIC J, et al. Phosphatidylinositol 4,5-bisphosphate triggers activation of focal adhesion kinase by inducing clustering and conformational changes [J]. Proceedings of the National Academy of Sciences of the United States of America, 2014, 111(31): E3177-E3186. [4]APONTE M, JIANG Wei, LAKKIS M, et al. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer [J]. Cancer Research, 2008, 68(14): 5839-5848. [5]YOU J J, YANG Chang-hao, YANG C M, et al. Cyr61 induces the expression of monocyte chemoattractant protein-1 via the integrin ανβ3, FAK, PI3K/Akt, and NF-κB pathways in retinal vascular endothelial cells [J]. Cellular Signalling, 2014, 26(1): 133-140. [6]LIM S T, CHEN Xiao-lei, LIM Y, et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation [J]. Molecular Cell, 2008, 29(1): 9-22. [7]MU Lin, ZHENG Wei, WANG Liang, et al. Focal adhesion kinase expression in ovarian endometriosis [J]. International Journal of Gynecology & Obstetrics, 2008, 101(2): 161-165. [8]王希波,刘艳.异位子宫内膜组织中黏附斑激酶表达及其与临床分期的关系 [J].山东医药,2017,57(18):90-91. [9]GUO Ying, LANG Xiao, LU Zhen, et al. MiR-10b directly targets ZEB1 and PIK3CA to curb adenomyotic epithelial cell invasiveness via upregulation of E-Cadherin and inhibition of Akt phosphorylation [J]. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry and Pharmacology, 2015, 35(6): 2169-2180. [10]BATLLE E, SANCHO E, FRANC C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells [J]. Nature Cell Biology, 2000, 2(2): 84-89. [11]CANO A, PREZ-MORENO M A, RODRIGO I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression [J]. Nature Cell Biology, 2000, 2(2): 76-83. [12]THIERY J P, ACLOQUE H, HUANG R Y, et al. Epithelial-mesenchymal transitions in development and disease [J]. Cell, 2009, 139(5): 871-890. [13]THIERY J P. Epithelial–mesenchymal transitions in development and pathologies [J]. Current Opinion in Cell Biology, 2003, 15(6): 740-746. [14]SERRELS A, CANEL M, BRUNTON V G, et al. Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement [J]. Cell Adhesion & Migration, 2011, 5(4): 360-365. [15]HAUCK C R, HSIA D A, PUENTE X S, et al. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth [J]. EMBO Journal, 2002, 21(23): 6289-6302. [16]SONODA Y, MATSUMOTO Y, FUNAKOSHI M, et al. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60 [J]. The Journal of Biological Chemistry, 2000, 275(21): 16309-16315. [17]CICCHINI C, LAUDADIO I, CITARELLA F, et al. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling [J]. Experimental Cell Research, 2008, 314(1): 143-152. [18]PLAYFORD M P, VADALI K, CAI Xinming, et al. Focal adhesion kinase regulates cell-cell contact formation in epithelial cells via modulation of Rho [J]. Experimental Cell Research, 2008, 314(17): 3187-3197. [19]CHEN Y J, LI H Y, HUANG C H, et al. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis [J]. The Journal of Pathology, 2010, 222(3): 261-270. [20]ORAZIZADEH M, RASHIDI I, SAREMI J, et al. Focal adhesion kinase (FAK) involvement in human endometrial remodeling during the menstrual cycle [J]. Iranian Biomedical Journal, 2009, 13(2): 95-101. [21]MU Lin, ZHENG Wei, WANG Liang, et al. Alteration of focal adhesion kinase expression in eutopic endometrium of women with endometriosis [J]. Fertility and Sterility, 2008, 89(3): 529-537.

相似文献/References:

[1]刘春霞,侯兴华,孙乃英,等.小剂量米非司酮对女性生殖/内分泌系统的影响[J].中国计划生育和妇产科,2011,(01):0.
 LIU Chun-xia,HOU Xing-hua,SUN Nai-ying,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[2]刘文霞,梁莉萍,吴舒慧,等.放置宫内节育器时行宫内膜细胞学检测300例分析[J].中国计划生育和妇产科,2011,(06):0.
 LIU Wen-xia,LIANG Li-ping,WU Shu-hui,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[3]方慧彬,杨建华,朱赟珊,等.宫腔镜子宫内膜切除术对服用他莫昔芬的绝经后乳腺癌术后患者子宫内膜增生的抑制作用[J].中国计划生育和妇产科,2013,(04):0.
 FANG Hui-bin,YANG Jian-hua,ZHU Yun-shan * ..[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[4]王丽,付静,曹缵孙,等.无痛人工流产术与女性生殖健康[J].中国计划生育和妇产科,2013,(05):0.
 WANG Li,FU Jing,CAO Zuan-sun,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[5]张静,刘莉.天然孕酮对绝经期子宫内膜增厚的治疗效果评价[J].中国计划生育和妇产科,2013,(05):0.
 ZHANG Jin,LIU Li,Maternal Care Centre,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[6]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[7]苏慧明,徐燕,黎颖雄,等.诺舒子宫内膜去除术治疗子宫腺肌病致月经过多的临床研究[J].中国计划生育和妇产科,2014,(03):0.
 SU Hui-ming,XU Yan,LI Ying-xiong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[8]毛世华,谭晓燕,范玲,等.高强度聚焦超声联合米非司酮治疗子宫腺肌病的疗效观察[J].中国计划生育和妇产科,2014,(05):0.
 MAO Shi-hua,TAN Xiao-yan,FAN Ling,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[9]邓淑珍.曼月乐宫内节育器治疗子宫腺肌病的疗效观察[J].中国计划生育和妇产科,2014,(05):0.
 DENG Shu-zhen,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[10]王宇慧,魏绍斌.中成药治疗子宫内膜异位症和子宫腺肌病的辨证应用[J].中国计划生育和妇产科,2015,(02):0.

备注/Memo

备注/Memo:
国家自然科学基金(81571412);北京市医院管理局临床医学发展专项-“扬帆计划”(ZYLX201406);首都医科大学基础-临床科研合作基金(16JL44)
更新日期/Last Update: 2018-02-25